Diagnósticos da América S.A. (BVMF:DASA3)
Brazil · Delayed Price · Currency is BRL 2.460
-0.050 (-1.99%)
At close: Jul 8, 2026
Diagnósticos da América Market Cap
Diagnósticos da América has a market cap or net worth of 3.14 billion as of July 8, 2026. Its market cap has increased by 83.23% in one year.
Market Cap
3.14B
Enterprise Value
9.86B
Revenue
9.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.46
Market Cap Chart
Since November 19, 2004, Diagnósticos da América's market cap has increased from 1.14B to 3.14B, an increase of 176.33%. That is a compound annual growth rate of 4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 3.14B | -44.71% |
| Dec 30, 2025 | 5.67B | 299.54% |
| Dec 30, 2024 | 1.42B | -80.24% |
| Dec 28, 2023 | 7.19B | -6.51% |
| Dec 29, 2022 | 7.69B | -58.42% |
| Dec 30, 2021 | 18.49B | -46.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 78.62B |
| Bradsaúde | 42.74B |
| Raia Drogasil | 29.85B |
| Hypera | 14.77B |
| Fleury | 8.55B |
| Empreendimentos Pague Menos | 2.68B |
| Blau Farmacêutica | 2.34B |
| Dimed S.A. Distribuidora de Medicamentos | 1.62B |